Glow Stack | TB-500 + BPC-157 + GHK-Cu | Buy Research-Grade Peptide Stack in Europe | ≥99% Purity

The Glow Stack combines three of the most extensively researched tissue repair and regenerative biology peptides — TB-500 (Thymosin Beta-4), BPC-157, and GHK-Cu — available to buy in Europe as a complete research-grade peptide combination for laboratory investigation into tissue repair mechanisms, angiogenesis, collagen biology, wound healing, anti-inflammatory signalling, and regenerative peptide pharmacology.

Laboratories and research institutions across the EU can order the verified, research-grade Glow Stack with fast international dispatch to Europe, full batch documentation, and ≥99% purity on all three compounds confirmed by HPLC and Mass Spectrometry.

✅ ≥99% Purity — HPLC & Mass Spectrometry Verified

✅ Batch-Specific Certificate of Analysis (CoA) — All Three Compounds

✅ Sterile Lyophilised Powder | GMP Manufactured

✅ TB-500 10mg + BPC-157 10mg + GHK-Cu 50mg

✅ Fast Dispatch to EU & Europe | Tracked Shipping

What is the Glow Stack?

The Glow Stack is a curated three-compound research peptide combination bringing together TB-500 (Thymosin Beta-4 fragment), BPC-157 (Body Protection Compound-157), and GHK-Cu (Copper Tripeptide) — three of the most extensively studied peptides in tissue repair, regenerative biology, and wound healing research. Each compound targets distinct but complementary molecular pathways involved in tissue regeneration — making the Glow Stack a comprehensive research tool for studying the overlapping and synergistic mechanisms through which peptide signalling drives repair processes across multiple tissue types.

The combination reflects a growing area of pre-clinical research interest in how different regenerative peptide classes interact and complement one another — with TB-500’s actin-sequestering and angiogenic properties, BPC-157’s pleiotropic repair and anti-inflammatory biology, and GHK-Cu’s gene expression regulatory and collagen synthesis-promoting profile collectively addressing tissue repair from three distinct mechanistic angles. Together these compounds cover the primary axes of tissue regeneration research — cellular migration and angiogenesis, growth factor upregulation and inflammation resolution, and extracellular matrix remodelling and gene regulation — making the Glow Stack relevant to a wide range of EU research applications in wound healing, musculoskeletal biology, skin biology, and regenerative peptide pharmacology.

The Three Components — What Each Peptide Does in Research

TB-500 (Thymosin Beta-4 Fragment) — 10mg

What is TB-500?

TB-500 is a synthetic peptide corresponding to the active actin-binding region of Thymosin Beta-4 (Tβ4) — a 43 amino acid endogenous peptide originally isolated from thymus tissue and now known to be one of the most abundant and ubiquitous intracellular peptides in mammalian cells. TB-500 corresponds specifically to the Tβ4 sequence region responsible for G-actin sequestration — the central molecular mechanism underlying Thymosin Beta-4’s effects on cell migration, tissue repair, and angiogenesis.

Thymosin Beta-4 is the primary G-actin sequestering peptide in most mammalian cells — binding monomeric actin to regulate its availability for filament polymerisation. This actin regulatory function has downstream consequences that extend far beyond cytoskeletal biology — influencing cell migration, wound healing, angiogenesis, and stem cell activation in ways that have made Tβ4 and its active fragment TB-500 among the most extensively researched repair peptides in the pre-clinical literature.

What Does TB-500 Do in Research?

• Actin sequestration and cell migration research — TB-500’s G-actin binding sequesters monomeric actin and promotes the cell migration-associated actin dynamics required for wound closure — making it a research tool for studying how actin regulatory peptides influence the cellular mechanics of tissue repair and wound healing.
• Angiogenesis research — TB-500 and Tβ4 have been extensively studied for their pro-angiogenic properties — promoting endothelial cell migration, tube formation, and new blood vessel development in wound and ischaemic tissue models. Studies have characterised upregulation of angiogenic factors including VEGF and MMP activation as components of its pro-angiogenic mechanism.
• Wound healing biology — studies have documented TB-500 effects on wound closure rates, granulation tissue formation, and re-epithelialisation parameters in pre-clinical wound healing models — making it a widely used tool for studying peptide-driven wound repair mechanisms.
• Cardiac repair research — Tβ4 and TB-500 have been examined in cardiac ischaemia models — with studies documenting cardiomyocyte survival promotion, cardiac progenitor cell activation, and improved functional recovery parameters following myocardial injury — establishing a cardiac repair research application alongside its wound healing profile.
• Musculoskeletal repair research — studies have examined TB-500 in muscle, tendon, and ligament injury models — characterising effects on satellite cell activation, fibroblast migration, and repair tissue formation parameters in pre-clinical musculoskeletal injury research.
• Anti-inflammatory signalling — studies have characterised TB-500’s anti-inflammatory properties — including downregulation of pro-inflammatory cytokines and modulation of innate immune cell activity at wound and injury sites — contributing to its overall repair-promoting biology.
• Hair follicle biology — Tβ4 has been studied for effects on hair follicle stem cell activation and hair growth cycle regulation — with TB-500 used as a research tool for examining peptide influences on follicular biology and stem cell-mediated hair regeneration.

BPC-157 (Body Protection Compound-157) — 10mg

What is BPC-157?

BPC-157 is a synthetic pentadecapeptide — a 15 amino acid sequence — derived from a protective protein found in human gastric juice. It is one of the most extensively studied synthetic peptides in pre-clinical repair biology, with a research literature spanning gastrointestinal healing, musculoskeletal repair, angiogenesis, neurological protection, and systemic anti-inflammatory biology developed across decades of investigation primarily from the University of Zagreb research programme led by Professor Predrag Sikiric.

BPC-157’s biological profile is characterised by its pleiotropic and systemic repair-promoting activity — producing effects across multiple tissue types and organ systems through mechanisms that include growth factor upregulation, angiogenesis promotion, nitric oxide system modulation, and direct effects on cellular repair processes. Its stability in gastric conditions — reflecting its origin from a gastric juice protein — and its activity following both systemic and oral administration have made it a practically useful and widely studied research tool for examining peptide-mediated tissue repair across diverse biological contexts.

What Does BPC-157 Do in Research?

• Gastrointestinal repair and gut biology — BPC-157 has its most extensively characterised research application in gastrointestinal biology — with studies documenting accelerated healing of gastric ulcers, intestinal anastomosis repair, inflammatory bowel disease models, and gut barrier restoration across a large body of pre-clinical literature. It is the reference compound for studying peptide-mediated gut repair.
• Musculoskeletal repair research — studies have examined BPC-157 in tendon, ligament, muscle, and bone repair models — documenting accelerated healing parameters, improved tissue organisation, and enhanced biomechanical properties in pre-clinical injury models. Tendon repair research represents one of its most extensively characterised musculoskeletal applications.
• Angiogenesis and vascular biology — BPC-157 promotes angiogenesis through VEGF upregulation and direct effects on endothelial cell migration and tube formation — providing a complementary pro-angiogenic mechanism alongside TB-500 in the Glow Stack combination.
• Nitric oxide system modulation — studies have characterised BPC-157’s interaction with the nitric oxide system as a key component of its repair-promoting mechanism — with research documenting effects on eNOS activity, NO production, and the downstream vascular and tissue effects of NO modulation.
• Neurological protection and repair — studies have examined BPC-157 in models of CNS and peripheral nervous system injury — documenting neuroprotective effects, promotion of nerve regeneration parameters, and improvements in neurological function following injury in pre-clinical models.
• Anti-inflammatory biology — BPC-157 produces consistent anti-inflammatory effects across multiple tissue types and inflammatory models — including suppression of pro-inflammatory cytokines and modulation of inflammatory cell recruitment — contributing to its overall repair-facilitating biological profile.
• Systemic organ protection — studies have characterised BPC-157 effects on organ injury parameters in models of drug toxicity, ischaemia, and systemic inflammatory challenge — with findings suggesting broad cytoprotective activity reflecting its origin as a gastric protective peptide.

GHK-Cu (Copper Tripeptide) — 50mg

What is GHK-Cu?

GHK-Cu (Glycine-Histidine-Lysine Copper) is a naturally occurring copper-binding tripeptide found in human plasma, urine, and saliva — where its concentrations decline significantly with age — and in tissue following injury, where it is released during extracellular matrix remodelling. GHK was first identified by Loren Pickart in 1973 as a plasma factor promoting liver cell growth, and subsequent decades of research have established it as one of the most biologically active short peptides known — with a research profile spanning wound healing, collagen biology, antioxidant regulation, anti-inflammatory signalling, and a remarkably broad gene expression regulatory programme characterised through microarray studies.

GHK-Cu’s copper coordination is central to its biology — the tripeptide forms a stable complex with copper(II) ions that both facilitates copper delivery to tissues and is required for many of its biological activities including superoxide dismutase-like antioxidant activity and collagen synthesis-promoting effects. Its naturally declining levels with age — falling from approximately 200ng/mL in young adults to around 80ng/mL in older individuals — have made it a significant subject of interest in ageing biology and skin research, where topical and systemic GHK-Cu effects on tissue quality and gene expression have been extensively studied.

What Does GHK-Cu Do in Research?

• Collagen synthesis and extracellular matrix research — GHK-Cu’s most characterised activity in wound healing biology is stimulation of collagen synthesis — with studies documenting upregulation of collagen I and III production in fibroblasts alongside effects on glycosaminoglycan synthesis and extracellular matrix remodelling enzyme expression. It is the reference compound for studying copper tripeptide effects on connective tissue biology.
• Wound healing research — studies have documented GHK-Cu effects on wound closure rates, granulation tissue formation, collagen deposition, and re-epithelialisation parameters in pre-clinical wound models — establishing it as a well-characterised peptide tool for wound healing biology research.
• Gene expression regulation research — microarray studies have documented GHK-Cu modulating the expression of over 4,000 human genes — including upregulation of tissue repair, anti-inflammatory, and antioxidant genes alongside downregulation of inflammatory and cancer-associated gene networks. This broad gene regulatory activity has established GHK-Cu as a research tool for studying copper-peptide-mediated transcriptional regulation.
• Antioxidant biology — GHK-Cu exhibits superoxide dismutase-like antioxidant activity through its copper coordination — and studies have characterised its effects on cellular oxidative stress parameters and antioxidant enzyme expression in tissue models relevant to wound healing and ageing research.
• Anti-inflammatory signalling — studies have documented GHK-Cu-mediated suppression of pro-inflammatory cytokine production — including TNF-α and IL-1β — and downregulation of NF-κB target gene expression, complementing the anti-inflammatory profiles of TB-500 and BPC-157 in the Glow Stack combination.
• Skin biology and ageing research — GHK-Cu’s effects on fibroblast function, collagen production, and skin gene expression have driven extensive research in skin biology — with studies examining its effects on dermal thickness, elastin production, and age-associated skin parameter changes in pre-clinical and in vitro skin models.
• Nerve regeneration research — studies have examined GHK-Cu effects on nerve growth factor expression and peripheral nerve regeneration parameters — contributing a neurotrophin-related research application to its repair biology profile.
• Stem cell and progenitor cell biology — research has characterised GHK-Cu effects on stem cell activation and differentiation — with studies examining its influence on mesenchymal stem cell behaviour and the stem cell microenvironment relevant to tissue regeneration research.
• Hair follicle research — GHK-Cu has been extensively studied in hair follicle biology — with studies characterising effects on follicular keratinocyte proliferation, hair cycle regulation, and hair growth parameters in pre-clinical models — complementing TB-500’s hair follicle research application within the Glow Stack.

What Do Studies Say About the Glow Stack Compounds?

Each component of the Glow Stack has an extensive, independently well-characterised research literature — and the combination addresses tissue repair biology from three mechanistically distinct angles.

TB-500 / Thymosin Beta-4 research: The Tβ4 and TB-500 research literature has consistently documented pro-angiogenic, pro-migratory, and repair-promoting effects across wound, cardiac, musculoskeletal, and neural tissue models. Studies have characterised actin sequestration as the foundational molecular mechanism, with downstream consequences for cell migration dynamics, angiogenic factor expression, and stem cell activation providing the biological basis for its broad tissue repair profile. Cardiac repair studies — including research documenting Tβ4’s ability to reactivate cardiac progenitor cells — represent a particularly high-profile area of the Tβ4 research literature.

BPC-157 research: BPC-157 has one of the largest pre-clinical repair biology literatures of any synthetic peptide — with studies consistently documenting accelerated healing across gastrointestinal, musculoskeletal, neurological, and vascular tissue types in rodent models. Its pleiotropic repair profile, stability characteristics, and activity across administration routes have established it as a widely used and practically convenient research tool. The University of Zagreb research programme has produced a large body of peer-reviewed literature characterising BPC-157 across multiple organ systems and injury models over several decades.

GHK-Cu research: GHK-Cu’s research base spans five decades — from Pickart’s initial identification of its liver cell growth-promoting activity to the comprehensive microarray studies documenting its broad gene regulatory programme. Studies have consistently documented collagen synthesis stimulation, wound healing promotion, antioxidant activity, and anti-inflammatory effects across multiple research models. The microarray findings characterising GHK-Cu’s modulation of over 4,000 genes — with patterns suggesting activation of tissue repair and suppression of inflammatory and degenerative gene networks — have been particularly influential in establishing it as a research tool of broad biological interest beyond simple wound healing applications.

Glow Stack vs Related Tissue Repair Peptide Research Compounds

Compound	Type	Primary Mechanism	Key Research Application
TB-500	Tβ4 active fragment	Actin sequestration, angiogenesis, cell migration	Wound healing, cardiac repair, musculoskeletal biology
BPC-157	Synthetic pentadecapeptide	Pleiotropic repair, VEGF, NO system, growth factors	Gut repair, tendon biology, neuroprotection, systemic repair
GHK-Cu	Copper-binding tripeptide	Collagen synthesis, gene regulation, antioxidant	Wound healing, skin biology, extracellular matrix, ageing
PEG MGF	PEGylated IGF-1 splice variant	Satellite cell activation, local IGF-1 signalling	Muscle repair, satellite cell biology
Epithalon	Pineal tetrapeptide	Telomerase activation, gene regulation	Longevity, telomere biology, cellular ageing
KPV	α-MSH tripeptide	NF-κB inhibition, anti-inflammatory	Gut inflammation, anti-inflammatory biology

Buying the Glow Stack in Europe — What’s Included

Every Glow Stack order dispatched to EU and European research institutions includes:

• Batch-Specific Certificate of Analysis (CoA) — TB-500, BPC-157, and GHK-Cu
• HPLC Chromatogram — all three compounds
• Mass Spectrometry Confirmation — all three compounds
• Sterility and Endotoxin Testing Reports
• Reconstitution Protocols for each compound
• Technical Research Support

Frequently Asked Questions — Glow Stack EU

Can I Buy the Glow Stack in the EU and Europe?

Yes. We supply the complete research-grade Glow Stack — TB-500 10mg, BPC-157 10mg, and GHK-Cu 50mg — with fast tracked international dispatch to all EU member states and wider European destinations including Germany, France, Netherlands, Spain, Italy, Poland, and beyond. All three compounds are supplied with individual batch documentation and packaging designed to maintain peptide integrity throughout transit. The Glow Stack is supplied strictly for laboratory research use only.

Why Are TB-500, BPC-157, and GHK-Cu Combined in the Glow Stack?

The three compounds address tissue repair biology through mechanistically distinct and complementary pathways — making their combination a comprehensive research tool for studying regenerative peptide biology across multiple repair mechanisms simultaneously. TB-500 targets actin dynamics and cell migration driving angiogenesis and re-epithelialisation. BPC-157 acts through growth factor upregulation, NO system modulation, and pleiotropic repair signalling across multiple tissue types. GHK-Cu drives extracellular matrix remodelling through collagen synthesis stimulation, antioxidant activity, and a broad gene regulatory programme. Together they cover the primary molecular axes of tissue repair — cellular mechanics, growth factor biology, and matrix remodelling — making the combination relevant to research examining how multiple repair peptide pathways interact in regenerative biology.

What is the Difference Between TB-500 and Full-Length Thymosin Beta-4?

Full-length Thymosin Beta-4 (Tβ4) is the complete 43 amino acid endogenous peptide with a broad biological profile that includes actin sequestration, nuclear signalling, and multiple activities not fully attributable to the actin-binding region alone. TB-500 is a synthetic peptide corresponding specifically to the actin-binding active region of Tβ4 — the sequence responsible for G-actin sequestration and many of the repair-relevant downstream effects. TB-500 provides a more targeted research tool focused on the actin-regulatory mechanism, while full-length Tβ4 is used when the complete biological profile including potential non-actin-mediated activities is the research focus. The two are studied as complementary tools in Thymosin Beta-4 biology research.

What is the Difference Between BPC-157 and TB-500 in Tissue Repair Research?

BPC-157 and TB-500 are both studied extensively in tissue repair research but through distinct mechanisms and with different tissue distribution profiles. BPC-157’s repair activity is broad and pleiotropic — spanning gastrointestinal, musculoskeletal, neurological, and vascular tissue — through mechanisms including growth factor upregulation, NO system modulation, and direct cellular repair effects. TB-500’s repair activity centres on actin sequestration-driven cell migration and angiogenesis — with particular strength in wound healing, cardiac repair, and musculoskeletal repair models where cell migration dynamics are central to tissue recovery. The two compounds are studied as complementary tools providing mechanistically distinct angles on peptide-driven tissue repair biology.

Why is GHK-Cu Included at a Higher Dose in the Glow Stack?

GHK-Cu is included at 50mg compared to 10mg for TB-500 and BPC-157 — reflecting the different research concentration ranges at which GHK-Cu is typically studied in tissue biology applications. As a tripeptide with a broad gene regulatory profile, GHK-Cu research protocols frequently employ higher mass quantities relative to larger peptides to achieve effective working concentrations across diverse experimental systems. The 50mg inclusion provides European research laboratories with a sufficient quantity for extended research protocols examining GHK-Cu’s collagen synthesis, gene regulation, antioxidant, and skin biology applications alongside the TB-500 and BPC-157 components.

How Are the Three Glow Stack Compounds Reconstituted?

Each compound should be reconstituted separately. Allow each vial to reach room temperature before opening. Add sterile water or appropriate laboratory buffer slowly down the vial wall and swirl gently — do not shake. Prepare each compound at your protocol’s required concentration, aliquot, and store at -80°C. For GHK-Cu — a copper-coordinated tripeptide — avoid reconstitution in buffers containing agents that may chelate copper and disrupt the Cu(II) coordination essential for biological activity. Standard peptide handling protocols apply to all three compounds.

How Quickly is the Glow Stack Delivered to Europe?

Orders are dispatched promptly via tracked international courier. Delivery to EU and European destinations typically takes 3–7 working days depending on location, with packaging designed to protect peptide stability of all three compounds throughout transit.

Product Specifications

Parameter	TB-500	BPC-157	GHK-Cu
Type	Thymosin Beta-4 active fragment	Synthetic pentadecapeptide	Copper-binding tripeptide
Quantity	10mg	10mg	50mg
Primary Mechanism	Actin sequestration, angiogenesis	Pleiotropic repair, VEGF, NO	Collagen synthesis, gene regulation, antioxidant
Primary Research Focus	Wound healing, cardiac, musculoskeletal	Gut repair, tendon, neuroprotection	Wound healing, skin, ECM biology
Purity	≥99%	≥99%	≥99%
Verification	HPLC & MS	HPLC & MS	HPLC & MS
Form	Sterile Lyophilised Powder	Sterile Lyophilised Powder	Sterile Lyophilised Powder
Storage	-20°C, protect from light	-20°C, protect from light	-20°C, protect from light
Intended Use	Research use only	Research use only	Research use only

Research Disclaimer

The Glow Stack — comprising TB-500, BPC-157, and GHK-Cu — is supplied exclusively for legitimate scientific research conducted within licensed laboratory environments. These products are not approved for human consumption, self-administration, or any therapeutic, clinical, or veterinary application. They must be handled solely by qualified researchers in compliance with applicable EU regulations, national legislation, and institutional ethics guidelines. By purchasing, you confirm these compounds will be used exclusively for approved in vitro or pre-clinical research purposes.